133 related articles for article (PubMed ID: 21446933)
1. Important details to be clarified about the effect of rectal ozone on the portal vein oxygenation.
Bocci V; Zanardi I; Travagli V
Br J Clin Pharmacol; 2011 Aug; 72(2):350-1; author reply 352. PubMed ID: 21446933
[No Abstract] [Full Text] [Related]
2. The effect of rectal ozone on the portal vein oxygenation and pharmacokinetics of propranolol in liver cirrhosis (a preliminary human study).
Zaky S; Fouad EA; Kotb HI
Br J Clin Pharmacol; 2011 Mar; 71(3):411-5. PubMed ID: 21284700
[TBL] [Abstract][Full Text] [Related]
3. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
Orban Schiopu AM; Balas BI; Diculescu M
Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
[TBL] [Abstract][Full Text] [Related]
4. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
[TBL] [Abstract][Full Text] [Related]
5. [Comparative effectiveness of different methods of diagnosis and correction of impaired portal circulation].
Tadzhiev IIa; Sergienko VB; Tsodikov GV; Tadzhieva NI; Topchiashvili ZA; Sapozhkova LP; Geĭnits AV
Klin Med (Mosk); 2004; 82(7):43-5. PubMed ID: 15449774
[TBL] [Abstract][Full Text] [Related]
6. Assessment of effects of propranolol on portal hemodynamics in cirrhosis by duplex ultrasonography.
Saigal S; Chawla Y; Dilawari JB
Indian J Gastroenterol; 1998 Apr; 17(2):51-2. PubMed ID: 9563219
[TBL] [Abstract][Full Text] [Related]
7. Total effective vascular compliance in patients with cirrhosis. Effects of propranolol.
Andreu V; Perello A; Moitinho E; Escorsell A; García-Pagán JC; Bosch J; Rodés J
J Hepatol; 2002 Mar; 36(3):356-61. PubMed ID: 11867179
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
Mills PR; Rae AP; Farah DA; Russell RI; Lorimer AR; Carter DC
Gut; 1984 Jan; 25(1):73-8. PubMed ID: 6360815
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J
Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
[TBL] [Abstract][Full Text] [Related]
10. [Adrenergic beta blockade in liver cirrhosis with portal hypertension? Doppler ultrasound measurement of the short-term effect of propranolol on the portal system].
Wruck U; Wermke W
Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):371-5. PubMed ID: 1615718
[No Abstract] [Full Text] [Related]
11. Propranolol and portal hypertension: should kids be on the block?
Schreiber RA
J Pediatr Gastroenterol Nutr; 1999 Jul; 29(1):10-1. PubMed ID: 10400096
[No Abstract] [Full Text] [Related]
12. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
[TBL] [Abstract][Full Text] [Related]
13. Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
Tripathi DM; Erice E; Lafoz E; García-Calderó H; Sarin SK; Bosch J; Gracia-Sancho J; García-Pagán JC
Am J Physiol Gastrointest Liver Physiol; 2015 Sep; 309(5):G301-9. PubMed ID: 26138461
[TBL] [Abstract][Full Text] [Related]
14. Portal hypertension, propranolol, and hepatic encephalopathy.
Lancet; 1982 Oct; 2(8303):879-80. PubMed ID: 6126739
[No Abstract] [Full Text] [Related]
15. Propranolol for portal hypertension. Evaluation of therapeutic response by direct measurement of portal vein pressure.
Rector WG
Arch Intern Med; 1985 Apr; 145(4):648-50. PubMed ID: 3985727
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients.
Castaño G; Viudez P; Riccitelli M; Sookoian S
Ann Hepatol; 2003; 2(1):36-40. PubMed ID: 15094704
[TBL] [Abstract][Full Text] [Related]
17. [Propranolol in portal hypertensive gastropathy].
Hüppe D; May B
Dtsch Med Wochenschr; 1991 Dec; 116(50):1935-6. PubMed ID: 1748075
[No Abstract] [Full Text] [Related]
18. β-2 Adrenergic receptor gene polymorphism and response to propranolol in cirrhosis.
Kong DR; Wang JG; Sun B; Wang MQ; Chen C; Yu FF; Xu JM
World J Gastroenterol; 2015 Jun; 21(23):7191-6. PubMed ID: 26109805
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial of propranolol for the prevention of initial bleeding in cirrhosis with portal hypertension.
Pagliaro L; Pasta L; D'Amico G; Filippazzo MG; Tinè F; Morabito A; Ferrari A; Marenco G; De Pretis G
N Engl J Med; 1986 Jan; 314(4):244-5. PubMed ID: 3510389
[No Abstract] [Full Text] [Related]
20. Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly.
Groszmann RJ
Gastroenterology; 1997 Nov; 113(5):1794-7. PubMed ID: 9352888
[No Abstract] [Full Text] [Related]
[Next] [New Search]
